Trombopanel Genetic is especially beneficial for individuals with a family history of thrombophilia, where the risk of developing thrombosis can be as high as 50%.
One of the main factors that cause or increase the risk of miscarriage is blood clotting.
According to official WHO data, 20% of pregnancies worldwide end in miscarriage.
In Latin America, it is estimated that one third of all women have a miscarriage at some time in their reproductive years.
Deepen your understanding of yourself to improve your health.
It is important to mention that not all individuals with these mutations will develop health problems; however, in the presence of other risk factors, such as family history or unhealthy lifestyles, the risk may be increased. Therefore, the detection of these mutations can be useful to establish preventive strategies, such as folate supplementation, to reduce homocysteine levels and the associated risk, as well as personalized preventive and therapeutic measures to reduce the risk of thrombosis and stroke in these patients.
What is the study based on?
This analysis detects mutations in specific genes such as AGT, F2, F5, F7, FGB, MTR, MTRR, MTHFR, and SERPINE1. For example, mutations in the F2 and F5 genes can significantly increase the risk of thrombotic events.
In addition, the test screens for the C677T and A1298C genetic variants in the MTHFR gene, which are associated with abnormalities in folate metabolism and can lead to elevated levels of homocysteine in the blood, a condition known as hyperhomocysteinemia. Hyperhomocysteinemia is a risk factor for thromboembolic and cardiovascular diseases. The C677T mutation, in particular, results in a thermolabile variant of the MTHFR enzyme with reduced ability to metabolize homocysteine, which may increase the risk of deep vein thrombosis and other cardiovascular complications.
- AGT
- AGT
- F2
- F5
- F7
- FGB
- MTR
- MTRR
- MTHFR
- MTHFR
- SERPINE1
For whom is the genetic thrombopanel study recommended?
- It is intended for women who have experienced any miscarriage in the trajectory of his life.
- Genetic analysis provides 99% accuracy in the identification of genetic variants related to the coagulation and allows for better management of the risk associated with the use of contraceptives.
- The detection of these mutations can be useful for establishing preventive strategies, such as supplementation with folates, to reduce the levels of homocysteine and the associated risk, as well as personalized preventive and therapeutic measures to reduce the risk of thrombosis and stroke in these patients.
Genetic Thrombosis Panel
- Digital and in-app reporting
The sample is easily collected using oral swabs; the process is painless, and you can collect the sample yourself using the kit. Results are available in approximately 7 business days. This test is part of our genomic medicine offerings and can be supplemented with modules such as pharmacogenetics, nutrigenetics, and dermagenetics to improve your quality of life.